The Growing Role of Immunotherapy and Combination Strategies in Pancreatic and Hepatobiliary Cancers

4,088
Total downloads
16k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 08 Apr 2025

Establishment of a nomogram based on Lasso Cox regression for albumin combined with systemic immune-inflammation index score to predict prognosis in advanced pancreatic carcinoma

Min Xu
Yu Long
Peisheng Chen
Ang Li
Jian Xin
Yonghua Xu

doi 10.3389/fonc.2025.1447055

684 views

SYSTEMATIC REVIEW

Published on 12 Feb 2025

Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis

Lingling Zhao
Cheng Xu
Jiewen Deng
Yang Ni

doi 10.3389/fonc.2025.1513394

1,139 views

ORIGINAL RESEARCH

Published on 05 Feb 2025

Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma

Ziting Peng
Jianhui Dong
Shuyao Tang
Jiaxu Shi
Tongdong Shi

doi 10.3389/fonc.2025.1498887

778 views
1 citation

CASE REPORT

Published on 29 Jan 2025

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients

Tara Seery
Lennie Sender
Omid Jafari
Frank Jones
Patricia Spilman
Sandeep B. Reddy
Patrick Soon-Shiong

doi 10.3389/fonc.2025.1472714

2,549 views

CASE REPORT

Published on 17 Dec 2024

Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma

Hongying Liu
Yun Wang
Qian Zhang
Nengwen Ke

doi 10.3389/fonc.2024.1458517

957 views

ORIGINAL RESEARCH

Published on 11 Dec 2024

Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model

Joanna Napp
Paulina Siebel
Hans Rausch
Kenny Kuchta
Thomas Efferth
Frauke Alves
Volker Ellenrieder
Silke Cameron

doi 10.3389/fonc.2024.1454291

1,518 views
1 citation

SYSTEMATIC REVIEW

Published on 11 Dec 2024

Prognostic role of systemic inflammation response index (SIRI) in patients with pancreatic cancer: a meta-analysis

Huifen Shen
Fei Zuo

doi 10.3389/fonc.2024.1465279

1,000 views
5 citations

ORIGINAL RESEARCH

Published on 02 Dec 2024

Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs

Lin Xu
Xu Che

doi 10.3389/fonc.2024.1478596

767 views
1 citation

CASE REPORT

Published on 24 Oct 2024

Case report: Combinations of immune checkpoint inhibitor, chemotherapy, and hyperthermia therapy avoid lymphatic recurrence in cholangiocarcinoma

Heng-Jui Chang
Chiao-Hsu Ke
Yu-Shan Wang

doi 10.3389/fonc.2024.1421340

1,069 views

SYSTEMATIC REVIEW

Published on 17 Oct 2024

Evaluating the benefits of adjuvant chemotherapy in patients with pancreatic cancer undergoing radical pancreatectomy after neoadjuvant therapy—a systematic review and meta-analysis

Jiahao Wu
Yike Zhang
Haodong Wang
Wenyi Guo
Chengqing Li
Yichen Yu
Han Liu
Feng Li

doi 10.3389/fonc.2024.1429386

1,192 views

CASE REPORT

Published on 15 Jul 2024

Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case

He-wei Zhang
Hai-bo Yu

doi 10.3389/fonc.2024.1428370

1,211 views
4 citations

Share on

Frontiers in Oncology

Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Impact

16kTopic views
11kArticle views
4,088Article downloads

View impact

Articles

Establishment of a nomogram based on Lasso Cox regression for albumin combined with systemic immune-inflammation index score to predict prognosis in advanced pancreatic carcinoma

Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis

Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients

Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma

Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model

Prognostic role of systemic inflammation response index (SIRI) in patients with pancreatic cancer: a meta-analysis

Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs

Case report: Combinations of immune checkpoint inhibitor, chemotherapy, and hyperthermia therapy avoid lymphatic recurrence in cholangiocarcinoma

Evaluating the benefits of adjuvant chemotherapy in patients with pancreatic cancer undergoing radical pancreatectomy after neoadjuvant therapy—a systematic review and meta-analysis

Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case

Frontiers in Oncology

Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers